AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea

NCT07571005 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

300

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity
Overweight
Obstructive Sleep Apnoea

Interventions

DRUG: NNC0487-0111
DRUG: Placebo (matched to NNC0487-0111)

Sponsor

Novo Nordisk A/S